Name | LGX 818 | CAS# | 1269440-17-6 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity. |
Get all suppliers by the below link:
2024-07-15 |
LGX818
Price: Inquiry |
2020-01-06 |
LGX-818(Encorafenib)
Price: $950.0 |
2021-01-25 |
encorafenib
Price: ¥Inquiry |
2024-05-09 |
Encorafenib
Price: ¥Inquiry |
2017-07-12 |
Encorafenib
Price: ¥Inquiry |
2017-12-16 |
Encorafenib
Price: ¥Inquiry |
2021-05-10 |
Encorafenib (LGX818)
Price: ¥Inquiry |
2021-02-06 |
LGX818
Price: ¥1839.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved